EP 1653996 A2 20060510 - USE OF GALACTOSE OXIDASE FOR SELECTIVE CHEMICAL CONJUGATION OF PROTRACTOR MOLECULES TO PROTEINS OF THERAPEUTIC INTEREST
Title (en)
USE OF GALACTOSE OXIDASE FOR SELECTIVE CHEMICAL CONJUGATION OF PROTRACTOR MOLECULES TO PROTEINS OF THERAPEUTIC INTEREST
Title (de)
VERWENDUNG VON GALACTOSEOXIDASE FÜR DIE SELEKTIVE CHEMISCHE KONJUGATION VON PROTRAKTOR-MOLEKÜLEN AN THERAPEUTISCH INTERESSIERENDE PROTEINE
Title (fr)
UTILISATION DE GALACTOSE OXYDASE POUR LA CONJUGAISON CHIMIQUE SELECTIVE DE MOLECULES D'EXTRACTION A DES PROTEINES D'INTERET THERAPEUTIQUE
Publication
Application
Priority
- DK 2004000530 W 20040809
- DK PA200301145 A 20030808
- US 49444703 P 20030812
- DK PA200301646 A 20031105
- US 51921203 P 20031112
Abstract (en)
[origin: WO2005014049A2] The invention provides synthesis and application of new structural well defined branched polymers as protraction agents for peptide and protein.
IPC 1-7
IPC 8 full level
A61K 38/44 (2006.01)
CPC (source: EP)
A61K 38/26 (2013.01); A61K 38/4846 (2013.01); A61K 47/60 (2017.07); C12Y 304/21021 (2013.01)
Citation (search report)
See references of WO 2005014035A2
Citation (examination)
- EP 0175617 A2 19860326 - CYTOGEN CORP [US]
- AU 720860 B2 20000615 - MACQUARIE RES LTD
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005014049 A2 20050217; WO 2005014049 A3 20050901; EP 1653996 A2 20060510; EP 1654004 A2 20060510; JP 2007501811 A 20070201; JP 2007501812 A 20070201; JP 2011157365 A 20110818; WO 2005014035 A2 20050217; WO 2005014035 A3 20050728
DOCDB simple family (application)
DK 2004000531 W 20040809; DK 2004000530 W 20040809; EP 04739027 A 20040809; EP 04739028 A 20040809; JP 2006522893 A 20040809; JP 2006522894 A 20040809; JP 2011051681 A 20110309